Long-Acting Injectable Buprenorphine
(LAIB) Masterclass
Brought to you by
Pharmacotherapy Area Based Networks
Originally Recorded Tuesday November 9th 2021

Speakers: Dr David Jacka - Addiction Medicine Specialist, Monash Health.
Dr Rob Weiss - Medical Director, Frankston Healthcare.
Angelo Pricolo - Harm Minimisation Pharmacist.
Teresa Strike - AOD Nurse Practitioner
This event is accredited with 4 RACGP points. Activity ID#303094
Register for Immediate Access
EVENT OVERVIEW
Long-acting Injectable Buprenorphine (LAIB) is a formulation of buprenorphine pharmacotherapy that has the promise to be a true game-changer in the area of Medication-Assisted Treatment of Opioid Dependence.

The proven safety record of buprenorphine, combined with a weekly to monthly dosing schedule provide very good reasons for both patients and prescribing clinicians to engage with this new treatment.
What You'll Learn In This Replay

Compare and contrast the effectiveness of long-acting injectable buprenorphine (LAIB) to sublingual buprenorphine and oral methadone in a harm minimisation setting

Outline the indications for treatment, as well as patient - centred factors that would make them less suited for treatment with long-acting injectable buprenorphine.

Describe the legal and logistic considerations for LAIB therapy including examples of how these are practically addressed.

Demonstrate best practice administration of both Buvidal and Sublocade formulations of LAIB.

MEET OUR EXPERTS & HOSTS
Dr David Jacka
Addiction Medicine Specialist at Monash Health.
David's areas of interest include acute illicit stimulant intoxication, improved methadone, buprenorphine and other opiate prescribing and the development of improved health and NSP services for people who inject drugs
Dr Rob Weiss
Medical Director
Frankston Healthcare.
Rob has served with the RACGP Addiction Medicine Committee and the National Faculty of Addiction Medicine; and has been active the in the FMP area on the Domestic Violence Advisory Group, the GP Network Mental Health Committee and the Pharmacotherapy Expert Advisory Group
Angelo Pricolo
Harm Minimisation Pharmacist.
Angelo Pricolo is a Melbourne based pharmacist who has been involved in the treatment of addiction and harm minimisation for 30 years. He has been a pharmacy owner, previous National Councillor of the Pharmacy Guild, and a sessional tutor at Monash University
Teresa Strike
AOD Nurse Practitioner
Terrie helped to establish the Pharmacotherapy and Wellbeing Clinic Service at the Sale Hospital's consulting suites that offers client consultations (outpatient) providing Opioid Replacement Therapy.
Host: Dr Ferghal Armstrong
Ferghal is a general practitioner, Addiction Medicine specialist and fellow of the Australasian Society of Lifestyle Medicine & is the CEO of Meducate
Host: Dr Anne Marie Diggins
Anne Marie has a special interest in providing holistic care for patients with AOD use, mental health and Hepatitis C conditions. She is also our Area 4 GP mentor and has extensive experience in community practice.
Register for Immediate Access
Brought to you by Pharmacotherapy Area Based Networks
50% Complete
Almost there
The Headline Goes Here
The Subheadline Goes Here
Audience is not selected
Your information is safe and will Never be shared
LAIB Masterclass Replay
Your information is safe and will Never be shared